Borg A - Search Results

1

Recurrence-free survival in breast cancer improved by adjuvant tamoxifen--especially for progesterone receptor positive tumors with a high proliferation.

Fernö M, Baldetorp B, Bendahl PO, Borg A, Ewers SB, Olsson H, Rydén S, Sigurdsson H, Killander D. Fernö M, et al. Among authors: borg a. Breast Cancer Res Treat. 1995;36(1):23-34. doi: 10.1007/BF00690181. Breast Cancer Res Treat. 1995. PMID: 7579503 Clinical Trial.

2

c-myc amplification is an independent prognostic factor in postmenopausal breast cancer.

Borg A, Baldetorp B, Fernö M, Olsson H, Sigurdsson H. Borg A, et al. Int J Cancer. 1992 Jul 9;51(5):687-91. doi: 10.1002/ijc.2910510504. Int J Cancer. 1992. PMID: 1612775

3

Flow cytometric DNA index and S-phase fraction in breast cancer in relation to other prognostic variables and to clinical outcome.

Fernö M, Baldetorp B, Borg A, Olsson H, Sigurdsson H, Killander D. Fernö M, et al. Among authors: borg a. Acta Oncol. 1992;31(2):157-65. doi: 10.3109/02841869209088897. Acta Oncol. 1992. PMID: 1622630

4

ERBB2 amplification in breast cancer with a high rate of proliferation.

Borg A, Baldetorp B, Fernö M, Killander D, Olsson H, Sigurdsson H. Borg A, et al. Oncogene. 1991 Jan;6(1):137-43. Oncogene. 1991. PMID: 1671531

5

HER-2/neu amplification predicts poor survival in node-positive breast cancer.

Borg A, Tandon AK, Sigurdsson H, Clark GM, Fernö M, Fuqua SA, Killander D, McGuire WL. Borg A, et al. Cancer Res. 1990 Jul 15;50(14):4332-7. Cancer Res. 1990. PMID: 1973070

6

Association of INT2/HST1 coamplification in primary breast cancer with hormone-dependent phenotype and poor prognosis.

Borg A, Sigurdsson H, Clark GM, Fernö M, Fuqua SA, Olsson H, Killander D, McGurie WL. Borg A, et al. Br J Cancer. 1991 Jan;63(1):136-42. doi: 10.1038/bjc.1991.28. Br J Cancer. 1991. PMID: 1989653 Free PMC article.

7

Flow cytometry in primary breast cancer: improving the prognostic value of the fraction of cells in the S-phase by optimal categorisation of cut-off levels.

Sigurdsson H, Baldetorp B, Borg A, Dalberg M, Fernö M, Killander D, Olsson H, Ranstam J. Sigurdsson H, et al. Among authors: borg a. Br J Cancer. 1990 Nov;62(5):786-90. doi: 10.1038/bjc.1990.380. Br J Cancer. 1990. PMID: 2245171 Free PMC article.

8

Indicators of prognosis in node-negative breast cancer.

Sigurdsson H, Baldetorp B, Borg A, Dalberg M, Fernö M, Killander D, Olsson H. Sigurdsson H, et al. Among authors: borg a. N Engl J Med. 1990 Apr 12;322(15):1045-53. doi: 10.1056/NEJM199004123221505. N Engl J Med. 1990. PMID: 2320064 Free article.

9

Estrogen and progesterone receptor analyses in more than 4,000 human breast cancer samples. A study with special reference to age at diagnosis and stability of analyses. Southern Swedish Breast Cancer Study Group.

Fernö M, Borg A, Johansson U, Norgren A, Olsson H, Rydén S, Sellberg G. Fernö M, et al. Among authors: borg a. Acta Oncol. 1990;29(2):129-35. doi: 10.3109/02841869009126532. Acta Oncol. 1990. PMID: 2334566

10

Prognostic significance of estrogen and progesterone receptors in stage II breast cancer.

Rydén S, Fernö M, Borg A, Hafström L, Möller T, Norgren A. Rydén S, et al. Among authors: borg a. J Surg Oncol. 1988 Apr;37(4):221-6. doi: 10.1002/jso.2930370402. J Surg Oncol. 1988. PMID: 3283457 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

855 results

Search Page

Filters